Literature DB >> 19838694

Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503.

Vilasack Thammavongsa1, Malinda Schaefer, Tracey Filzen, Kathleen L Collins, Mary Carrington, Naveen Bangia, Malini Raghavan.   

Abstract

Residue 116 of major histocompatibility complex (MHC) class I heavy chains is an important determinant of assembly, that can influence rates of ER-Golgi trafficking, binding to the transporter associated with antigen processing (TAP), tapasin dependence of assembly, and the efficiency and specificity of peptide binding. Here, we investigated assembly and peptide-binding differences between HLA-B*3501(S116) and HLA-B*3503(F116), two alleles differing only at position 116 of the MHC class I heavy chain, that are associated respectively with normal or rapid AIDS progression. A reduced intracellular maturation rate was observed for HLA-B*3503 in HIV-infected and uninfected cells, which correlated with enhanced binding of HLA-B*3503 to TAP. No significant differences in the intrinsic efficiency of in vitro peptide binding by HLA-B*3501 and HLA-B*3503 were measurable with several common peptides or peptide libraries, and both allotypes were relatively tapasin-independent for their assembly. However, thermostability differences between the two allotypes were measurable in a CD4(+) T cell line. These findings suggest that compared to HLA-B*3501, a reduced intracellular peptide repertoire for HLA-B*3503 could contribute to its slower intracellular trafficking and stronger association with rapid AIDS progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19838694      PMCID: PMC2971690          DOI: 10.1007/s00251-009-0399-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  44 in total

1.  HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins.

Authors:  H R Turnquist; H J Thomas; K R Prilliman; C T Lutz; W H Hildebrand; J C Solheim
Journal:  Eur J Immunol       Date:  2000-10       Impact factor: 5.532

2.  HLA and AIDS: a cautionary tale.

Authors:  S J O'Brien; X Gao; M Carrington
Journal:  Trends Mol Med       Date:  2001-09       Impact factor: 11.951

3.  Functional roles of TAP and tapasin in the assembly of M3-N-formylated peptide complexes.

Authors:  T Chun; A G Grandea; L Lybarger; J Forman; L Van Kaer; C R Wang
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Optimization of the MHC class I peptide cargo is dependent on tapasin.

Authors:  Anthony P Williams; Chen Au Peh; Anthony W Purcell; James McCluskey; Tim Elliott
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

5.  A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes.

Authors:  S Morel; A Ooms; A Van Pel; T Wölfel; V G Brichard; P van der Bruggen; B J Van den Eynde; G Degiovanni
Journal:  Int J Cancer       Date:  1999-12-10       Impact factor: 7.396

6.  Retraction. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

Authors:  Luk Van Parijs; Yosef Refaeli; James D Lord; Brad H Nelson; Abul K Abbas; David Baltimore
Journal:  Immunity       Date:  2009-04-17       Impact factor: 31.745

7.  Use of chimeric proteins to investigate the role of transporter associated with antigen processing (TAP) structural domains in peptide binding and translocation.

Authors:  S Arora; P E Lapinski; M Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

8.  Calreticulin recognizes misfolded HLA-A2 heavy chains.

Authors:  Laura Mancino; Syed Monem Rizvi; Philip Edward Lapinski; Malini Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

9.  Tapasin enhances peptide-induced expression of H2-M3 molecules, but is not required for the retention of open conformers.

Authors:  L Lybarger; Y Y Yu; T Chun; C R Wang; A G Grandea; L Van Kaer; T H Hansen
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

10.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.

Authors:  X Gao; G W Nelson; P Karacki; M P Martin; J Phair; R Kaslow; J J Goedert; S Buchbinder; K Hoots; D Vlahov; S J O'Brien; M Carrington
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

View more
  9 in total

1.  Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27.

Authors:  Begoña Galocha; José A López de Castro
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

2.  Large-scale characterization of peptide-MHC binding landscapes with structural simulations.

Authors:  Chen Yanover; Philip Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-08       Impact factor: 11.205

3.  Distinct assembly profiles of HLA-B molecules.

Authors:  Syed Monem Rizvi; Nasir Salam; Jie Geng; Ying Qi; Jay H Bream; Priya Duggal; Shehnaz K Hussain; Jeremy Martinson; Steven M Wolinsky; Mary Carrington; Malini Raghavan
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

4.  Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity.

Authors:  Brogan Yarzabek; Anita J Zaitouna; Eli Olson; Gayathri N Silva; Jie Geng; Aviva Geretz; Rasmi Thomas; Sujatha Krishnakumar; Daniel S Ramon; Malini Raghavan
Journal:  Elife       Date:  2018-07-10       Impact factor: 8.140

5.  Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway.

Authors:  Natasha Del Cid; Elise Jeffery; Syed Monem Rizvi; Ericca Stamper; Larry Robert Peters; William Clay Brown; Chester Provoda; Malini Raghavan
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

6.  The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.

Authors:  Minzhong Tang; James A Lautenberger; Xiaojiang Gao; Efe Sezgin; Sher L Hendrickson; Jennifer L Troyer; Victor A David; Li Guan; Carl E McIntosh; Xiuchan Guo; Yuming Zheng; Jian Liao; Hong Deng; Michael Malasky; Bailey Kessing; Cheryl A Winkler; Mary Carrington; Guy Dé The; Yi Zeng; Stephen J O'Brien
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

7.  Allele-Independent Turnover of Human Leukocyte Antigen (HLA) Class Ia Molecules.

Authors:  Claudia Prevosto; M Farooq Usmani; Sarah McDonald; Aleksandra M Gumienny; Tim Key; Reyna S Goodman; J S Hill Gaston; Michael J Deery; Robert Busch
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

8.  Selected HLA-B allotypes are resistant to inhibition or deficiency of the transporter associated with antigen processing (TAP).

Authors:  Jie Geng; Anita J Zaitouna; Malini Raghavan
Journal:  PLoS Pathog       Date:  2018-07-11       Impact factor: 6.823

9.  HLA-C downregulation by HIV-1 adapts to host HLA genotype.

Authors:  Nathaniel D Bachtel; Gisele Umviligihozo; Suzanne Pickering; Talia M Mota; Hua Liang; Gregory Q Del Prete; Pramita Chatterjee; Guinevere Q Lee; Rasmi Thomas; Mark A Brockman; Stuart Neil; Mary Carrington; Bosco Bwana; David R Bangsberg; Jeffrey N Martin; Esper G Kallas; Camila S Donini; Natalia B Cerqueira; Una T O'Doherty; Beatrice H Hahn; R Brad Jones; Zabrina L Brumme; Douglas F Nixon; Richard Apps
Journal:  PLoS Pathog       Date:  2018-09-04       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.